Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ADGM
Valuation N/A
Adagio Medical Holdings, Inc.
Price$0.13
Model IV—
P/IV—
Market implies +20.6%/yr
AEMD
Valuation N/A
AETHLON MEDICAL INC
Price$6.01
Model IV—
P/IV—
Market implies +21.2%/yr
ALGN
Deeply overvalued
ALIGN TECHNOLOGY INC
Price$141.03
Model IV$66.07
P/IV2.32
Premium +113%
Return to IV: -53.2%
Market implies +16.6%/yr
vs model +7.2% · above model
AMIX
Valuation N/A
Autonomix Medical, Inc.
Price$3.13
Model IV—
P/IV—
Limited data — see page
ANGO
Overvalued
ANGIODYNAMICS INC
Price$11.23
Model IV$8.70
P/IV1.79
Premium +29%
Return to IV: -22.6%
Market implies +0.8%/yr
vs model +2.0% · in line
ANIK
Deeply overvalued
Anika Therapeutics, Inc.
Price$19.23
Model IV$5.90
P/IV3.54
Premium +226%
Return to IV: -69.3%
Market implies +15.7%/yr
vs model +2.0% · above model
AORT
Fairly valued
ARTIVION, INC.
Price$21.21
Model IV$19.00
P/IV1.20
Premium +12%
Return to IV: -10.4%
Market implies -3.0%/yr
vs model +10.2% · below model
APT
Deeply overvalued
ALPHA PRO TECH LTD
Price$6.00
Model IV$4.31
P/IV1.21
Premium +39%
Return to IV: -28.2%
Market implies +7.3%/yr
vs model +5.9% · in line
APYX
Valuation N/A
Apyx Medical Corp
Price$2.36
Model IV—
P/IV—
Market implies +18.1%/yr
ARAY
Valuation N/A
ACCURAY INC
Price$0.24
Model IV—
P/IV—
Market implies -34.4%/yr
vs model +2.0% · below model
ATEC
Deeply undervalued
Alphatec Holdings, Inc.
Price$10.35
Model IV$24.78
P/IV0.40
Discount 58%
Return to IV: +139.4%
Market implies -17.0%/yr
vs model +33.1% · below model
ATRC
Overvalued
AtriCure, Inc.
Price$52.84
Model IV$45.89
P/IV1.17
Premium +15%
Return to IV: -13.2%
Market implies -3.5%/yr
vs model +18.2% · below model
AVNS
Valuation N/A
AVNS
Price$24.99
Model IV—
P/IV—
Limited data — see page
AVR
Valuation N/A
Anteris Technologies Global Corp.
Price$6.63
Model IV—
P/IV—
Market implies +87.4%/yr
AXGN
Deeply overvalued
Axogen, Inc.
Price$36.18
Model IV$12.11
P/IV3.68
Premium +199%
Return to IV: -66.5%
Market implies +10.3%/yr
vs model +15.3% · below model
BAX
Deeply overvalued
BAXTER INTERNATIONAL INC
Price$23.90
Model IV$7.34
P/IV3.20
Premium +226%
Return to IV: -69.3%
Market implies +21.3%/yr
vs model +6.4% · above model
BBLG
Valuation N/A
Bone Biologics Corp
Price$0.47
Model IV—
P/IV—
Limited data — see page
BBLGW
Valuation N/A
Bone Biologics Corp
Price$6.54
Model IV—
P/IV—
Limited data — see page
BBNX
Fairly valued
Beta Bionics, Inc.
Price$17.43
Model IV$18.23
P/IV1.04
Discount 4%
Return to IV: +4.6%
Market implies -3.1%/yr
vs model +50.0% · below model
BDMD
Deeply overvalued
Baird Medical Investment Holdings Ltd
Price$0.79
Model IV$0.17
P/IV4.35
Premium +358%
Return to IV: -78.2%
Market implies +20.3%/yr
vs model +2.0% · above model
BDMDW
Valuation N/A
Baird Medical Investment Holdings Ltd
Price$0.03
Model IV—
P/IV—
Market implies -37.5%/yr
vs model +2.0% · below model
BDX
Fairly valued
BECTON DICKINSON & CO
Price$182.75
Model IV$205.39
P/IV0.86
Discount 11%
Return to IV: +12.4%
Market implies +5.0%/yr
vs model +8.0% · below model
BEAT
Valuation N/A
HeartBeam, Inc.
Price$0.49
Model IV—
P/IV—
Limited data — see page
BEATW
Valuation N/A
HeartBeam, Inc.
Price$0.01
Model IV—
P/IV—
Limited data — see page
BFLY
Valuation N/A
Butterfly Network, Inc.
Price$8.03
Model IV—
P/IV—
Market implies +54.3%/yr
BJDX
Valuation N/A
Bluejay Diagnostics, Inc.
Price$0.82
Model IV—
P/IV—
Market implies +2.0%/yr
BLFS
Valuation N/A
BIOLIFE SOLUTIONS INC
Price$38.61
Model IV—
P/IV—
Market implies +44.0%/yr
BSX
Deeply undervalued
BOSTON SCIENTIFIC CORP
Price$42.04
Model IV$67.97
P/IV0.62
Discount 38%
Return to IV: +61.7%
Market implies +3.0%/yr
vs model +11.2% · below model
BVS
Deeply overvalued
Bioventus Inc.
Price$12.69
Model IV$8.83
P/IV1.45
Premium +44%
Return to IV: -30.5%
Market implies +11.2%/yr
vs model +9.2% · in line
BWAY
Deeply overvalued
Brainsway Ltd.
Price$11.47
Model IV$4.90
P/IV2.37
Premium +134%
Return to IV: -57.3%
Market implies +20.4%/yr
vs model +12.1% · above model
CARL
Deeply undervalued
CARLSMED, INC.
Price$14.05
Model IV$23.40
P/IV0.60
Discount 40%
Return to IV: +66.5%
Market implies -9.0%/yr
vs model +50.0% · below model
CBLL
Deeply overvalued
Ceribell, Inc.
Price$23.15
Model IV$10.72
P/IV2.16
Premium +116%
Return to IV: -53.7%
Market implies +8.8%/yr
vs model +40.3% · below model
CDRE
Deeply overvalued
Cadre Holdings, Inc.
Price$24.83
Model IV$18.24
P/IV1.47
Premium +36%
Return to IV: -26.6%
Market implies +11.4%/yr
vs model +9.8% · in line
CERS
Deeply overvalued
CERUS CORP
Price$2.28
Model IV$1.07
P/IV2.84
Premium +113%
Return to IV: -53.1%
Market implies +13.1%/yr
vs model +10.0% · above model
CLGN
Valuation N/A
CollPlant Biotechnologies Ltd
Price$3.97
Model IV—
P/IV—
Market implies +37.8%/yr
CLPT
Valuation N/A
ClearPoint Neuro, Inc.
Price$10.49
Model IV—
P/IV—
Market implies +23.2%/yr
CNMD
Deeply undervalued
CONMED Corp
Price$45.11
Model IV$65.94
P/IV0.54
Discount 32%
Return to IV: +46.2%
Market implies +1.7%/yr
vs model +9.4% · below model
CNXU
Valuation N/A
Conexeu Sciences Inc.
Price$3.45
Model IV—
P/IV—
Limited data — see page
COCH
Valuation N/A
Envoy Medical, Inc.
Price$0.66
Model IV—
P/IV—
Market implies +45.3%/yr
vs model +15.0% · above model
COCHW
Valuation N/A
Envoy Medical, Inc.
Price$0.04
Model IV—
P/IV—
Market implies +18.8%/yr
vs model +15.0% · above model
CODX
Valuation N/A
Co-Diagnostics, Inc.
Price$1.09
Model IV—
P/IV—
Market implies +36.1%/yr
vs model +2.0% · above model
COO
Overvalued
COOPER COMPANIES, INC.
Price$54.30
Model IV$44.25
P/IV1.38
Premium +23%
Return to IV: -18.5%
Market implies +10.3%/yr
vs model +9.2% · in line
CTSO
Valuation N/A
Cytosorbents Corp
Price$3.73
Model IV—
P/IV—
Market implies +29.6%/yr
vs model +2.0% · above model
CUPR
Valuation N/A
Cuprina Holdings (Cayman) LTD
Price$1.90
Model IV—
P/IV—
Market implies +101.7%/yr
CV
Valuation N/A
CapsoVision, Inc
Price$6.62
Model IV—
P/IV—
Market implies +19.2%/yr
vs model +15.3% · above model
CVRX
Deeply undervalued
CVRx, Inc.
Price$1.68
Model IV$10.57
P/IV0.53
Discount 84%
Return to IV: +529.4%
Market implies -36.3%/yr
vs model +44.4% · below model
DCTH
Fairly valued
DELCATH SYSTEMS, INC.
Price$15.04
Model IV$15.48
P/IV1.06
Discount 3%
Return to IV: +2.9%
Market implies -1.2%/yr
vs model +50.0% · below model
DRIO
Undervalued
DarioHealth Corp.
Price$5.43
Model IV$7.61
P/IV1.02
Discount 29%
Return to IV: +40.1%
Market implies -13.8%/yr
vs model +2.2% · below model
DRTS
Valuation N/A
Alpha Tau Medical Ltd.
Price$14.00
Model IV—
P/IV—
Limited data — see page
DRTSW
Valuation N/A
Alpha Tau Medical Ltd.
Price$3.56
Model IV—
P/IV—
Limited data — see page
DXCM
Fairly valued
DEXCOM INC
Price$84.41
Model IV$76.86
P/IV0.96
Premium +10%
Return to IV: -8.9%
Market implies +14.0%/yr
vs model +16.6% · in line
ECOR
Valuation N/A
electroCore, Inc.
Price$9.51
Model IV—
P/IV—
Market implies +108.6%/yr
EDAP
Deeply overvalued
EDAP TMS SA
Price$5.43
Model IV$3.55
P/IV1.22
Premium +53%
Return to IV: -34.6%
Market implies -0.8%/yr
vs model +15.0% · below model
ELMD
Fairly valued
Electromed, Inc.
Price$27.80
Model IV$24.49
P/IV1.54
Premium +14%
Return to IV: -11.9%
Market implies +12.1%/yr
vs model +14.0% · in line
EMBC
Deeply undervalued
Embecta Corp.
Price$5.75
Model IV$45.50
P/IV0.12
Discount 87%
Return to IV: +691.2%
Market implies -27.0%/yr
vs model +6.4% · below model
ENOV
Deeply undervalued
Enovis CORP
Price$17.43
Model IV$54.70
P/IV0.41
Discount 68%
Return to IV: +213.8%
Market implies -18.6%/yr
vs model +12.1% · below model
ESTA
Valuation N/A
ESTABLISHMENT LABS HOLDINGS INC.
Price$60.61
Model IV—
P/IV—
Market implies +26.8%/yr
vs model +13.6% · above model
EW
Deeply overvalued
Edwards Lifesciences Corp
Price$84.24
Model IV$50.87
P/IV1.70
Premium +66%
Return to IV: -39.6%
Market implies +12.5%/yr
vs model +7.5% · above model
EYE
Deeply overvalued
National Vision Holdings, Inc.
Price$16.74
Model IV$9.07
P/IV1.85
Premium +85%
Return to IV: -45.8%
Market implies +13.8%/yr
vs model +7.6% · above model
FEED
Deeply undervalued
ENvue Medical, Inc.
Price$0.36
Model IV$3.95
P/IV0.23
Discount 91%
Return to IV: +997.0%
Market implies -50.0%/yr
vs model +10.8% · below model